What ORKYN' does

ORKYN' (legal entity Pharma Dom S.A.) is a French home healthcare provider and wholly-owned subsidiary of Air Liquide Healthcare, founded circa 1985 and headquartered in Bagneux, France. The company delivers at-home medical services and equipment across six therapeutic areas — sleep apnea (CPAP/PPC), chronic respiratory insufficiency (oxygen therapy and non-invasive ventilation), diabetes (insulin pump therapy), Parkinson's disease (apomorphine pump), immune disorders (immunoglobulin perfusion), and home medical equipment for loss of autonomy — to a patient base exceeding 300,000 across France, supported by 1,900+ employees and 62 operational sites.

The core technology platform combines connected medical device provisioning with a proprietary remote monitoring (télésuivi) system that analyzes continuous patient data via an alert algorithm, routed to a dedicated expert nurse cell for proactive intervention. Adjacent digital products include the ORKYN'&Moi patient mobile application and portal (treatment tracking, scheduling, travel customs documentation) and the ALTIVIE home equipment platform. Documented clinical outcomes include 83% CPAP adherence above 4 hours/night among remotely monitored patients and 2x VNI treatment continuation at 5 months versus classical care.

ORKYN' operates a reimbursement-driven managed services model: all services are initiated via physician prescription and paid by Assurance Maladie and mutuelles under the LPP (Liste des Produits et Prestations) framework, with no upfront patient cost in standard coverage scenarios. The go-to-market is entirely physician-referral-led with no consumer marketing, distribution is direct via ORKYN's national site network and ~100 HAD hospital partnerships, and the customer base is long-tail (300,000+ patients, 25,000+ referring professionals). Revenue is not publicly disclosed.

Name

ORKYN'

Legal name

Pharma Dom S.A.

Website

https://orkyn.fr

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

501–1,000 employees

Short description

ORKYN' is a French home healthcare provider (subsidiary of Air Liquide Healthcare) delivering at-home respiratory, diabetes, Parkinson's, immune disorder, and home medical equipment services to 300,000+ patients across France via physician prescriptions reimbursed under the LPP framework.

Ownership category

akta.pro rank

Product category

Home Healthcare Services

NAICS

Home Health Care Services (621610)

SIC

Services-Home Health Care Services (8082), Services-Health Services (8000)

akta.pro primary industry

Home Respiratory & Sleep Therapy Providers (DME-Integrated) (HLAFAEAF)

akta.pro secondary industries

Home Health Remote Patient Monitoring & Virtual Nursing Providers (HLAFAEAN), Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF)

Keywords

• Home healthcare services
• Respiratory care equipment
• Remote patient monitoring
• Insulin pump therapy
• Home medical equipment

Headquarters

HQ city

Gentilly

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Reimbursed Home Health Services (Assurance Maladie + Mutuelle): ORKYN' delivers home health services and medical equipment prescribed by physicians, covered by French national health insurance (Assurance Maladie) and supplementary mutuelles. Patients generally have no upfront costs. Revenue flows from social security reimbursement rates set under the LPP (Liste des Produits et Prestations). Services include: ventilation (VNI), oxygen therapy, CPAP for sleep apnea, insulin pumps, apomorphine pumps, perfusion, and home medical equipment.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

ORKYN' delivers prescription-driven at-home healthcare services in France across chronic respiratory insufficiency, sleep apnea, diabetes, Parkinson's disease, immune disorders, and loss of autonomy, providing medical device provision, installation, patient training, in-home follow-up, and remote monitoring (télé-suivi). Services are reimbursed through French Assurance Maladie and mutuelles under the LPP framework, and the company operates a network of 62 sites supported by an expert nurse remote monitoring cell and the ORKYN'&Moi patient digital platform.

Product overview

ORKYN' operates as a home healthcare services provider offering a unified portfolio of medical treatments and at-home care services organized around six therapeutic areas: sleep apnea (PPC treatment), respiratory insufficiency (oxygen therapy and non-invasive ventilation), diabetes (insulin pump management), Parkinson's disease (apomorphine pump), immune disorders (immunoglobulin perfusion), and home medical equipment (via ALTIVIE platform). The core services are complemented by patient engagement tools including the Orkyn'&Moi digital portal and remote monitoring (télésuivi) capabilities. Services are delivered through a network of 62 sites across France, coordinated with healthcare professionals to ensure continuous, personalized patient care at home.

Differentiator

Problem solved

Functional benefit

Brands

• Orkyn'&Moi: Patient portal and mobile application for patient follow-up and engagement
• ALTIVIE

Products and services

• Sleep Apnea Treatment (PPC/CPAP) At-home treatment for obstructive sleep apnea using Positive Airway Pressure (PPC/CPAP) devices, including device provision, patient initiation, follow-up visits, and remote monitoring (télé-suivi) to support therapy adherence. Delivered to patients prescribed by pulmonologists, sleep specialists, or general practitioners and reimbursed under French Assurance Maladie.
• Home Oxygen Therapy (Oxygénothérapie) At-home oxygen therapy for patients with chronic respiratory insufficiency, providing oxygen concentrators, liquid oxygen tanks, or gaseous oxygen cylinders with installation, patient training, ongoing refills, and follow-up visits under BPDO-certified dispensing practices.
• Non-Invasive Ventilation (VNI) Treatment At-home non-invasive ventilation treatment for chronic respiratory failure using ventilator devices and masks, including remote monitoring (télé-suivi) and follow-up services delivered through a dedicated expert nurse cell.
• Diabetes Treatment (Insulin Pump Therapy) Diabetes management including insulin pump initiation (including ambulatory initiation to reduce hospitalization), patient training, and ongoing adherence coaching via programs such as Cap Observance, delivered to adults and children prescribed by diabetologists or endocrinologists.
• Parkinson's Disease Treatment (Apomorphine Pump) At-home treatment for advanced Parkinson's disease using continuous subcutaneous apomorphine infusion via pump to manage motor symptoms, with specialized installation, training, and coordination with neurologists and other care professionals.
• Immunoglobulin Perfusion Treatment Home immunoglobulin perfusion for patients with primary immunodeficiencies (DIP, DICV/CVID), secondary immunodeficiencies, and multiple myeloma, including at-home administration, patient support, and coordination with prescribing internists, immunologists, and hematologists.
• ALTIVIE Home Medical Equipment Platform Digital platform for equipping patient homes with medical equipment to maintain autonomy and safety, covering mobility aids, beds, bathroom safety equipment, lifting/transfer aids, and daily living solutions for elderly or loss-of-autonomy patients.
• ORKYN'&Moi Patient Digital Portal and Mobile Application Patient-facing digital portal and mobile application providing personalized health management features including access to treatment data, appointment scheduling, customs attestation for travel with medical devices, and secure communication with ORKYN' care teams. Available on web and as iOS/Android mobile apps.
• Télé-suivi (Remote Monitoring) for Chronic Respiratory Insufficiency Remote monitoring service for chronic respiratory insufficiency patients (including VNI), featuring a dedicated expert nurse team that analyzes daily patient data transmitted by connected medical devices, manages alerts, and intervenes proactively to maintain treatment effectiveness.

Quantifiable outcome

• 85% of ORKYN' patients are remotely monitored (télésuivi)
• +5 more outcomes

Named customers2 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core and minor.

• ~100 Hospital Establishments (HAD partners)coreStrategic or Co-development PartnerORKYN' is a historic partner of Hospitalisation à Domicile (HAD) establishments, working with approximately 100 hospital partners to ensure continuity of care between hospital and home for patients with complex respiratory and neurological conditions. ORKYN' provides its expertise, trains hospital staff on medical devices, and coordinates with hospital teams for seamless patient transitions.
• Air Liquide HealthcarecoreOthersORKYN' is a subsidiary (filiale) of Air Liquide Healthcare, part of the Air Liquide Group. As part of this parent organization, ORKYN' benefits from the group's ethical commitments, investment capacity, and healthcare ecosystem. Air Liquide is the #1 European player in home healthcare.
• International Partners (for patient travel abroad)minorChannel Partner/ Reseller/ DistributorFor patients traveling abroad, ORKYN' works with international partners who can ensure treatment continuity during the patient's stay outside France. This allows ORKYN' to support its patient base across borders.
• FFAAIR (Fédération Française des Associations et Amicales de Malades, Insuffisants ou handicapés Respiratoires)minorStrategic or Co-development PartnerFFAAIR initiated the creation of the Patient-Home Health Provider Charter, of which ORKYN' was one of the first signatories. ORKYN' is committed to respecting all duties under this charter, which establishes reciprocal commitments between patient rights and home health provider obligations.
• Scientific Committee / Board of ExpertscoreStrategic or Co-development PartnerORKYN' is surrounded by scientific committees and expert boards in Parkinson's disease, diabetes, and chronic respiratory insufficiency to define best practices, develop clinical studies, and advance research. These expert panels guide ORKYN's innovation and quality improvement programs.

Scale indicators15 records

Recent moves2 records

Expansion highlights6 records

Direct peers

• Asten Santé: French home healthcare provider delivering respiratory care (CPAP, oxygen, ventilation), perfusion, nutrition, and insulin pump services. Directly comparable to ORKYN' in business model, therapeutic portfolio, and French regulatory/LPP reimbursement framework.
• Bastide Group (Bastide Le Confort Médical): French listed home medical equipment and respiratory care provider offering CPAP, oxygen, ventilation, perfusion, and home-care equipment. Comparable to ORKYN' in respiratory home therapy distribution and DME integration.
• Elivie: French home healthcare provider offering respiratory care, perfusion, diabetes, and nutrition services to chronic patients at home. Closely matches ORKYN' in service model, therapeutic breadth, and prescription-driven reimbursement in France.
• Santélys: French associative (non-profit) home healthcare provider delivering home respiratory, perfusion, and chronic-care services. Operates in the same French home health services category as ORKYN' with overlapping patient populations and service lines.

Broad incumbents

• Linde Healthcare: Linde plc's home healthcare division providing home oxygen, respiratory therapies, and chronic care services across multiple European countries. Comparable as a larger pan-European home respiratory and chronic-care operator with overlapping capabilities.
• ResMed: Global leader in sleep apnea (CPAP) devices and connected health/RPM platforms (myAir). Comparable to ORKYN' in sleep apnea focus and remote monitoring infrastructure, but operates primarily as a manufacturer with broader respiratory portfolio.
• Philips Respironics: Royal Philips' sleep and respiratory care business offering CPAP, ventilators, and home-care solutions. Overlaps with ORKYN' in home respiratory therapy and DME, though operates as part of a much larger global health technology portfolio.

Regional players

• Apria Healthcare (Owens & Minor): US home medical equipment and respiratory care provider serving chronic patients with sleep, oxygen, ventilation, and infusion therapies. Directly comparable service model and patient segments to ORKYN', but operating in the US market.
• AdaptHealth: US-listed home medical equipment provider with strong respiratory and sleep focus, serving patients with CPAP, oxygen, ventilation, and chronic-care equipment. Mirrors ORKYN' in business model and therapeutic mix, scaled to the US geography.
• Amedisys (Optum): US home health and hospice provider delivering skilled nursing, therapy, and chronic-care services to patients at home. Comparable to ORKYN' in vertically integrated at-home care delivery and multi-state (national) service footprint, but US-based and recently acquired by UnitedHealth's Optum.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Orkyn
• LinkedInlinkedin.com/company/orkyn

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ORKYN'